HAL | Histidine ammonia-lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
HEMGN | Hemogen | | | | | | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
IGLL1 | Immunoglobulin lambda-like polypeptide 1 | CD markers Disease related genes Plasma proteins
| | | | | Group enriched |
IL21 | Interleukin 21 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
IL34 | Interleukin 34 | Predicted secreted proteins
| | | | | Group enriched |
ITGAD | Integrin, alpha D | CD markers Predicted membrane proteins
| | | | | Group enriched |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
L1TD1 | LINE-1 type transposase domain containing 1 | | | | | | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| | | | | Group enriched |
LRTM1 | Leucine-rich repeats and transmembrane domains 1 | Predicted membrane proteins
| | | | | Group enriched |
LSP1 | Lymphocyte-specific protein 1; Uncharacterized protein | | | | | | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MMP25 | Matrix metallopeptidase 25 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
NKX2-5 | NK2 homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
NLRP4 | NLR family, pyrin domain containing 4 | | | | | | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Transcription factors
| | | | | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
NTNG2 | Netrin G2 | Predicted secreted proteins
| | | | | Group enriched |
OTOA | Otoancorin | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted membrane proteins
| | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes
| | | | | Group enriched |
PLA2G2D | Phospholipase A2, group IID | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIGLEC11 | Sialic acid binding Ig-like lectin 11 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SIT1 | Signaling threshold regulating transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SPATC1 | Spermatogenesis and centriole associated 1 | | | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TCTEX1D1 | Tctex1 domain containing 1 | | | | | | Group enriched |
TLR10 | Toll-like receptor 10 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TLX1 | T-cell leukemia homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TRAPPC3L | Trafficking protein particle complex 3-like | | | | | | Group enriched |